Cargando…
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study
BACKGROUND: High on-aspirin treatment platelets reactivity (HPR) is a significant problem in long-term secondary prevention of cardiovascular events. We hypothesize that imbalance between platelets MMPs/TIMPs results in cardiovascular disorders. We also explored whether chronically elevated blood gl...
Autores principales: | Kuliczkowski, Wiktor, Radomski, Marek, Gąsior, Mariusz, Urbaniak, Joanna, Kaczmarski, Jacek, Mysiak, Andrzej, Negrusz-Kawecka, Marta, Bil-Lula, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523290/ https://www.ncbi.nlm.nih.gov/pubmed/28770228 http://dx.doi.org/10.1155/2017/9352015 |
Ejemplares similares
-
Does Arterial Hypertension Affect Plasma Levels of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Stable Coronary Artery Disease? A Preliminary Study
por: Kuliczkowski, Wiktor, et al.
Publicado: (2019) -
MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease
por: Kobusiak-Prokopowicz, Malgorzata, et al.
Publicado: (2018) -
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016) -
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas
por: Meneses-García, Abelardo, et al.
Publicado: (2008) -
Cardioprotective effect of MMP‐2‐inhibitor‐NO‐donor hybrid against ischaemia/reperfusion injury
por: Krzywonos‐Zawadzka, Anna, et al.
Publicado: (2019)